A grey decision-making trial and evaluation laboratory approach for evaluating the disruption risk factors in the Emergency Life-Saving Drugs supply chains
Emergency Life-Saving Drugs (ELSDs) are among the highest-priority healthcare necessities since they must be administered immediately to save patient lives and prevent complications in the most critical conditions. Due to this reason, it is vital to ensure a continuous and undisrupted supply chain (...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-11-01
|
| Series: | Healthcare Analytics |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772442522000600 |